Unimark Remedies Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is LANTHANUM CARBONATE OCTAHYDRATE, with a corresponding US DMF Number 23254.
Remarkably, this DMF maintains an Active status since its submission on November 05, 2009, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of December 14, 2015, and payment made on December 08, 2015, indicating their dedication to facilitating drug approvals, Categorized as Type II